https://pubmed.ncbi.nlm.nih.gov/38113528

This 7-year study found that the antibiotic lefamulin showed potent activity against common and less common bacterial pathogens causing respiratory tract infections and hospitalized pneumonia, and resistance to lefamulin was rare.